Laxmi Dental Ltd

AI
Laxmi Dental Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Laxmi Dental Ltd

₹ 196 -0.05%
06 Nov - close price
laxmidentallimited.com BSE: 544339 NSE: LAXMIDENTL
About

Incorporated in 2004, Laxmi Dental is an integrated dental products company offering a comprehensive portfolio of Dental Products[1]

Key Points

Leading Dental Company[1]
Laxmi Dental is India’s only end-to-end integrated dental products company, operating across the full dental value chain — dental laboratory services, clear aligners, aligner materials & machines, and paediatric dental products. It is the second-largest domestic dental lab player and the largest Indian export dental laboratory

Website BSE NSE
  • Market Cap ₹ 1,081 Cr.
  • Current Price ₹ 196
  • High / Low ₹ 345 / 156
  • Stock P/E 56.6
  • Book Value ₹ 47.0
  • Dividend Yield 0.00 %
  • ROCE 12.4 %
  • ROE 9.97 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 60.2% CAGR over last 5 years
  • Debtor days have improved from 69.9 to 54.2 days.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Working capital days have increased from 110 days to 188 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Part of BSE Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
34.92 39.14 43.23 41.99 43.35 42.68 50.11 54.26 48.45 55.74 55.20 58.19
33.81 32.96 34.75 37.22 37.77 35.34 40.15 46.58 43.88 47.71 46.34 49.45
Operating Profit 1.11 6.18 8.48 4.77 5.58 7.34 9.96 7.68 4.57 8.03 8.86 8.74
OPM % 3.18% 15.79% 19.62% 11.36% 12.87% 17.20% 19.88% 14.15% 9.43% 14.41% 16.05% 15.02%
3.07 3.87 10.52 2.92 2.04 3.33 2.68 3.38 -2.12 1.99 2.60 2.04
Interest 1.10 1.19 1.08 0.86 1.01 0.70 0.14 0.14 0.23 0.27 0.26 0.30
Depreciation 2.49 2.34 2.19 2.13 2.67 2.83 2.48 2.64 3.06 3.33 3.26 3.94
Profit before tax 0.59 6.52 15.73 4.70 3.94 7.14 10.02 8.28 -0.84 6.42 7.94 6.54
Tax % -200.00% 8.74% 7.31% 19.15% 18.53% 41.74% 21.56% 20.77% 123.81% -5.92% 22.29% 28.59%
1.76 5.96 14.59 3.80 3.21 4.18 7.86 6.57 -1.89 6.80 6.17 4.67
EPS in Rs 0.65 2.21 5.25 1.37 0.62 0.76 1.43 1.20 -0.34 1.24 1.12 0.85
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
112 63 113 126 139 171 209 218
110 59 109 119 128 144 178 187
Operating Profit 3 4 4 6 12 27 31 30
OPM % 2.6% 7% 3.1% 5% 8% 16% 15% 14%
1 0 4 8 14 19 6 5
Interest 3 3 3 4 5 4 1 1
Depreciation 6 6 7 9 9 10 12 14
Profit before tax -5 -4 -2 1 12 32 24 20
Tax % 5% 9% 118% 0% -85% 18% 19%
-5 -4 -4 1 23 26 19 16
EPS in Rs -1.77 -1.61 -1.63 0.53 8.41 4.69 3.52 2.87
Dividend Payout % 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 27%
3 Years: 18%
TTM: 14%
Compounded Profit Growth
10 Years: %
5 Years: 60%
3 Years: 247%
TTM: -12%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -37%
Return on Equity
10 Years: %
5 Years: 12%
3 Years: 15%
Last Year: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Equity Capital 0.31 0.31 0.31 0.31 0.31 11 11 11
Reserves 44 40 36 28 51 212 236 248
36 36 41 42 53 5 11 12
28 29 29 37 31 48 33 27
Total Liabilities 109 105 106 108 136 276 291 298
38 41 32 35 33 40 54 60
CWIP 0 0 0 0 0 0 0 0
Investments 16 16 17 14 14 17 79 76
54 48 57 59 89 219 159 162
Total Assets 109 105 106 108 136 276 291 298

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
10 10 -4 10 5 47 -35
-15 -9 3 -6 -6 -49 -46
6 -1 1 -1 -2 104 -3
Net Cash Flow 0 1 -1 3 -3 102 -85
Free Cash Flow -7 1 -2 3 -2 34 -52
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 340% 247% -84% 156% 45% 180% -96%

Ratios

Standalone / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 90 95 73 85 88 68 54
Inventory Days 189 377 195 162 196 132 125
Days Payable 184 310 147 151 82 196 45
Cash Conversion Cycle 95 162 120 95 201 4 134
Working Capital Days 21 9 27 20 71 72 188
ROCE % 0% 1% 6% 19% 17% 12%

Insights

In beta
Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Aligner Cases Sold (Bizdent)
cases

Log in to view insights

Please log in to see hidden values.

Login
Digital Units Penetration - Domestic Lab
% of domestic lab units
Digital Units Penetration - International Lab
% of international lab units
Domestic Lab Metal-Free Revenue Share
% of domestic lab revenue
Domestic Lab Units Sold
units
International Lab Units Sold
units
Paediatric Crowns Units Sold (Kids-e-Dental)
units
Intraoral Scanner Units Sold
scanners

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
41.70% 41.70% 41.70% 41.70% 41.77% 41.80% 41.75%
34.24% 33.59% 32.39% 32.45% 31.20% 30.10% 6.57%
12.86% 14.30% 11.85% 10.82% 10.52% 10.89% 10.68%
11.19% 10.39% 14.05% 15.01% 16.50% 17.21% 41.00%
No. of Shareholders 29,48227,95737,90938,63538,16136,93736,680

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls